优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301166 优宁维

已收盘 02-02 15:00:00

{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":32.36,"timestamp":1770015813000,"preClose":32.56,"halted":0,"volume":1499591,"delay":0,"changeRate":-0.0061,"floatShares":56918700,"shares":86666700,"eps":-0.2194,"marketStatus":"已收盘","change":-0.2,"latestTime":"02-02 15:00:00","open":32.6,"high":33.18,"low":32.22,"amount":49275900,"amplitude":0.0295,"askPrice":32.38,"askSize":16,"bidPrice":32.36,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.2194,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":5,"adr":0,"adjPreClose":32.56,"symbolType":"stock","openAndCloseTimeList":[[1769995800000,1770003000000],[1770008400000,1770015600000]],"highLimit":35.82,"lowLimit":29.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86666668,"isCdr":false,"pbRate":1.39,"roa":"--","roe":"--","epsLYR":0.12,"committee":-0.755511,"marketValue":2805000000,"turnoverRate":0.0263,"status":1,"floatMarketCap":1842000000},"requestUrl":"/m/hq/s/301166","defaultTab":"news","newsList":[{"id":"2608788196","title":"股市必读：优宁维（301166）预计2025年全年归属净利润亏损1500万元至3000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608788196","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608788196?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:34","pubTimestamp":1769978051,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，优宁维报收于32.56元，上涨0.18%，换手率2.01%，成交量1.14万手，成交额3718.14万元。业绩披露要点业绩预告优宁维发布业绩预告，预计2025年全年归属净利润亏损1500万元至3000万元。2025年度业绩预告上海优宁维生物科技股份有限公司预计2025年度归属于上市公司股东的净利润亏损1,500万元至3,000万元，上年同期为盈利1,014.9万元；扣除非经常性损益后的净利润亏损3,448万元至4,948万元，上年同期亏损1,511万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166"],"gpt_icon":0},{"id":"2607753039","title":"优宁维（301166）披露关于注销募集资金专项账户的公告，1月29日股价下跌0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607753039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607753039?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:26","pubTimestamp":1769700375,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，优宁维报收于32.5元，较前一交易日下跌0.28%，最新总市值为28.17亿元。该股当日开盘32.59元，最高33.07元，最低32.21元，成交额达4256.93万元，换手率为2.29%。近日，上海优宁维生物科技股份有限公司发布《关于注销募集资金专项账户的公告》。截至公告日，部分募集资金专户仍存续。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2606752009","title":"优宁维：可为客户提供单/多因子相关检测分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2606752009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606752009?lang=zh_cn&edition=full","pubTime":"2026-01-28 09:12","pubTimestamp":1769562749,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维01月27日在投资者关系平台上答复投资者关心的问题。此外，公司全资子公司上海乐备实生物技术有限公司作为向客户提供实验室检测服务的实施主体，可为客户提供单/多因子相关检测分析、多色流式检测以及多色组化检测等检测服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800008447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2605741935","title":"股市必读：优宁维（301166）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605741935","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605741935?lang=zh_cn&edition=full","pubTime":"2026-01-23 02:03","pubTimestamp":1769104995,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，优宁维报收于32.69元，上涨0.37%，换手率2.24%，成交量1.28万手，成交额4162.67万元。同时公司通过参与投资的股权投资基金，适时寻找合适的投资标的，探索相应的外延发展布局，推动公司持续、稳健发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300001044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2605660104","title":"优宁维：围绕抗体上下游寻求协同发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2605660104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605660104?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:48","pubTimestamp":1769071694,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维01月22日在投资者关系平台上答复投资者关心的问题。后续如有明确进展，公司将及时履行信息披露义务，投资者可关注公司后续披露的相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200026702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2604111182","title":"优宁维（301166）披露使用闲置自有资金进行现金管理的进展公告，1月20日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111182?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:32","pubTimestamp":1768919532,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，优宁维报收于32.35元，较前一交易日上涨0.34%，最新总市值为28.04亿元。公司近日发布公告称，上海优宁维生物科技股份有限公司使用闲置自有资金进行现金管理，近期购买多笔结构性存款产品，涉及平安银行、浦发银行、民生银行等，累计金额较大，产品期限从数月到一年不等，预期年化收益率区间为0.45%至2.30%，资金来源均为自有资金。截至2026年1月20日，未到期自有资金现金管理余额为91,600万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2603625732","title":"优宁维：建立智能化冷链仓储物流系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2603625732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603625732?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:48","pubTimestamp":1768438092,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维01月14日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500006539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2603632906","title":"股市必读：优宁维（301166）1月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632906?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:57","pubTimestamp":1768330628,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，优宁维报收于32.5元，上涨2.33%，换手率4.52%，成交量2.57万手，成交额8385.8万元。公司全资子公司上海乐备实生物技术有限公司可为客户提供实验室检测相关服务，主要面向国内高等院校、科研院所、医院和生物医药企业等科研端。当日关注点来自交易信息汇总：1月13日主力资金净流出797.5万元，显示主力资金持续离场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400001431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2603039515","title":"优宁维：子公司提供实验室检测服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603039515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603039515?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:09","pubTimestamp":1768288153,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：冷总，您好，公司作为抗体专家，有没有为医药的生产，研发及检测提供CRO，CDMO相关服务？优宁维回复：投资者您好。公司全资子公司上海乐备实生物技术有限公司可为客户提供实验室检测相关服务，主要面向国内高等院校、科研院所、医院和生物医药企业等科研端。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300019619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2601383788","title":"股市必读：优宁维（301166）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601383788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601383788?lang=zh_cn&edition=full","pubTime":"2026-01-08 02:51","pubTimestamp":1767811868,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，优宁维报收于30.79元，上涨0.03%，换手率1.85%，成交量1.06万手，成交额3246.84万元。董秘最新回复投资者： 冷总，您好，请问公司在脑机接口领域布局了哪些？当日关注点来自交易信息汇总：1月7日主力资金净流入154.9万元，显示主力对优宁维短期走势持积极态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800001360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2601582303","title":"优宁维：公司参与投资的股权投资基金投向覆盖医疗健康等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2601582303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601582303?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:33","pubTimestamp":1767756792,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：祁总，公司参股的创投基金有没有参与脑机接口？优宁维回复：投资者您好，公司参与投资的股权投资基金投向覆盖医疗健康等领域，投资者可关注相关基金的投资进展。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700013718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166","159760"],"gpt_icon":0},{"id":"2601000794","title":"优宁维（301166）披露关于回购公司股份的进展公告，1月5日股价上涨3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000794?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:33","pubTimestamp":1767609203,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，优宁维报收于30.66元，较前一交易日上涨3.3%，最新总市值为26.57亿元。该股当日开盘29.89元，最高30.68元，最低29.68元，成交额达4881.69万元，换手率为2.82%。公司近日发布公告，就回购公司股份的进展情况作出说明。根据公告，上海优宁维生物科技股份有限公司于2025年4月10日召开董事会及监事会会议，于2025年5月13日召开股东大会，审议通过回购公司股份方案。本次回购符合相关规定，公司后续将继续实施回购计划并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500029227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2601200657","title":"优宁维：建立现代化仓储物流配送系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2601200657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601200657?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:45","pubTimestamp":1767599118,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维01月04日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2601006804","title":"优宁维：借助大数据完善客户画像","url":"https://stock-news.laohu8.com/highlight/detail?id=2601006804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601006804?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:45","pubTimestamp":1767599117,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维01月04日在投资者关系平台上答复投资者关心的问题。作为实现一站式服务的重要支撑，公司不断迭代升级在线商城，上线UCRM、CRM、实验室管理系统、OA、OMS等系统，助力公司业务和管理效率提升，并积极借助大数据等技术，基于公司积累的客户数据，完善客户画像，以更加精准地为客户提供相关产品和服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","159739","BK0250"],"gpt_icon":0},{"id":"2600601640","title":"每周股票复盘：优宁维（301166）部分募投项目结项并补流235.01万","url":"https://stock-news.laohu8.com/highlight/detail?id=2600601640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600601640?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:50","pubTimestamp":1767383420,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，优宁维报收于29.68元，较上周的29.75元下跌0.24%。本周，优宁维12月29日盘中最高价报30.02元。优宁维当前最新总市值25.72亿元，在生物制品板块市值排名48/51，在两市A股市值排名4820/5181。本周关注点公司公告汇总：优宁维同意将两个募投项目结项，节余募集资金235.01万元永久补充流动资金。公司公告汇总：优宁维将“线上营销网络与信息化建设项目”和“蛋白及抗体试剂研发技改项目”延期至2026年12月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2595778553","title":"优宁维（301166）披露部分募投项目延期公告，12月31日股价下跌0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595778553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595778553?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:58","pubTimestamp":1767175119,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，优宁维报收于29.68元，较前一交易日下跌0.07%，最新总市值为25.72亿元。该股当日开盘29.9元，最高29.9元，最低29.44元，成交额达2417.49万元，换手率为1.43%。近日，上海优宁维生物科技股份有限公司发布公告称，公司于2025年12月30日召开第四届董事会第十次会议，审议通过部分募投项目延期的议案。本次延期未改变项目实施主体、方式、投资规模及募集资金用途，不影响公司正常经营，不存在变相改变募集资金投向的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100033191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2595635687","title":"优宁维：期待为辉瑞及默沙东提供服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2595635687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595635687?lang=zh_cn&edition=full","pubTime":"2025-12-30 11:34","pubTimestamp":1767065679,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)12月30日在投资者关系平台上答复投资者关心的问题。投资者提问：祁总，公司说海外市场是公司要大力拓展的业务，公司有没有和辉瑞制药或者默沙东有合作呢？优宁维回复：投资者您好，公司客户主要为国内高等院校、科研院所、医院和生物医药企业等。随着公司自主品牌产品持续丰富、海外市场的持续拓展，公司期待为包括辉瑞制药及默沙东在内的生物医药头部企业提供相关产品和服务。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000016159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2595763811","title":"优宁维：借助大数据完善客户画像","url":"https://stock-news.laohu8.com/highlight/detail?id=2595763811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595763811?lang=zh_cn&edition=full","pubTime":"2025-12-30 11:34","pubTimestamp":1767065678,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维12月30日在投资者关系平台上答复投资者关心的问题。作为实现一站式服务的重要支撑，公司不断迭代升级在线商城，上线UCRM、CRM、实验室管理系统、OA、OMS等系统，助力公司业务和管理效率提升，并积极借助大数据等技术，基于公司积累的客户数据，完善客户画像，以更加精准地客户提供相关产品和服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000016153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159739","301166","BK0250"],"gpt_icon":0},{"id":"2594291994","title":"优宁维：针对海外市场，目前主要通过海外电商平台、参加海外展会等方式进行市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2594291994","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594291994?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:38","pubTimestamp":1766756280,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：董秘你好，公司在医药电商领域有布局宣传销售公司产品吗？优宁维（301166.SZ）12月26日在投资者互动平台表示，公司目前形成了线上+线下双渠道销售模式，线上渠道方面，主要通过自有商城、微信、抖音等平台以及第三方专业服务网站展示、销售公司产品，提升公司产品曝光度；此外针对海外市场，目前主要通过海外电商平台、参加海外展会等方式进行市场拓展。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-26/doc-inhecwez7848519.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-26/doc-inhecwez7848519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2594028352","title":"优宁维：已在海口等全国设18个办事处及11个子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2594028352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594028352?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:33","pubTimestamp":1766622784,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)12月24日在投资者关系平台上答复投资者关心的问题。投资者提问：祁总，公司有在海南设立子公司吗？优宁维回复：投资者您好。公司作为全国布局的生命科学一站式服务商，已在海口等全国各地设有18个办事处及11个子公司。未来公司将会根据业务开展情况，综合考虑优化业务布局，借助相关地区的政策优势加快业务发展。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500004853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770018043828,"stockEarnings":[{"period":"1week","weight":-0.0181},{"period":"1month","weight":0.097},{"period":"3month","weight":0.015},{"period":"6month","weight":-0.0381},{"period":"1year","weight":0.1832},{"period":"ytd","weight":0.097}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.1567},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.0376}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"9893人(较上一季度减少13.19%)","perCapita":"5753股","listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","registeredCapital":"8666万元","survey":"　　上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂、生命科学仪器及耗材、综合技术服务。","listedPrice":86.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}